Literature DB >> 16059633

Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation.

Guangheng Li1, Hairong Peng, Karin Corsi, Arvydas Usas, Anne Olshanski, Johnny Huard.   

Abstract

UNLABELLED: After intramuscular implantation, BMP4-expressing NIH/3T3 fibroblasts and BMP4-expressing C2C12 myoblasts can promote ectopic cartilage and bone formation. Fibroblasts tend to undergo chondrogenesis, whereas myoblasts primarily undergo osteogenesis. These results suggest that endochondral bone formation may involve different cell types, a finding that could have major implications for the tissue engineering of bone and cartilage.
INTRODUCTION: The delivery of BMP4 through cell-based gene therapy can trigger ectopic endochondral bone formation in skeletal muscle. We hypothesized that, when stimulated with or transduced to express BMP4, different types of cells residing within skeletal muscle might participate in different stages of endochondral bone formation.
MATERIALS AND METHODS: We compared the responses of a fibroblast cell line (NIH/3T3), a myoblast cell line (C2C12), primary fibroblasts, and primary myoblasts to BMP4 stimulation in vitro. We then transduced the four cell populations to express BMP4 and compared their ability to promote ectopic endochondral bone formation in skeletal muscle.
RESULTS: Under the influence of BMP4 in vitro and in vivo, NIH/3T3 cells differentiated toward both chondrogenic and osteogenic lineages, whereas most C2C12 cells underwent primarily osteogenic differentiation. NIH/3T3 cells genetically modified to express BMP4 induced delayed but more robust cartilage formation than did genetically modified C2C12 cells, which promoted rapid ossification. These differences in terms of the timing and amount of cartilage and bone formation persisted even after we introduced a retrovirus encoding dominant negative Runx2 (DNRunx2) into the C2C12 cells, which interferes with the function of Runx2. Superior osteogenic potential was also displayed by the primary myoblasts in vitro and in vivo compared with the primary fibroblasts. The different proliferation abilities and differentiation potentials exhibited by these cells when influenced by BMP4 may at least partially explain the differing roles that BMP4-expressing myogenic cells and BMP4-expressing fibroblastic cells play in endochondral bone formation.
CONCLUSIONS: Our findings suggest that the process of endochondral bone formation in skeletal muscle after delivery of BMP4 involves different cell types, including fibroblastic cells, which are more involved in the chondrogenic phases, and myoblastic cells, which are primarily involved in osteogenesis. These findings could have important implications for the development of tissue engineering applications focused on bone and cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16059633     DOI: 10.1359/JBMR.050513

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

Review 1.  Emerging role of circulating calcifying cells in the bone-vascular axis.

Authors:  Gian Paolo Fadini; Marcello Rattazzi; Tomoyuki Matsumoto; Takayuki Asahara; Sundeep Khosla
Journal:  Circulation       Date:  2012-06-05       Impact factor: 29.690

Review 2.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

3.  The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation.

Authors:  Guangheng Li; Karin Corsi-Payne; Bo Zheng; Arvydas Usas; Hairong Peng; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

4.  Identification and characterization of chondrogenic progenitor cells in the fascia of postnatal skeletal muscle.

Authors:  Guangheng Li; Bo Zheng; Laura B Meszaros; Joseph B Vella; Arvydas Usas; Tomoyuki Matsumoto; Johnny Huard
Journal:  J Mol Cell Biol       Date:  2011-07-04       Impact factor: 6.216

5.  The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy.

Authors:  Annemarie C Brescia; Megan M Simonds; Suzanne M McCahan; Paul T Fawcett; Carlos D Rose
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

6.  Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts.

Authors:  Young-Dan Cho; Won-Joon Yoon; Woo-Jin Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Gene Lee; Young Ku; Andre J van Wijnen; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

7.  Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway.

Authors:  Jamie R Genthe; Jaeki Min; Dana M Farmer; Anang A Shelat; Jose A Grenet; Wenwei Lin; David Finkelstein; Karen Vrijens; Taosheng Chen; R Kiplin Guy; Wilson K Clements; Martine F Roussel
Journal:  ACS Chem Biol       Date:  2017-08-29       Impact factor: 5.100

8.  Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.

Authors:  Bashar M Altaani; Ammar M Almaaytah; Suha Dadou; Khouloud Alkhamis; Mousa H Daradka; Wael Hananeh
Journal:  Pharm Res       Date:  2020-04-06       Impact factor: 4.200

9.  Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis.

Authors:  M C Gozo; P-J Aspuria; D-J Cheon; A E Walts; D Berel; N Miura; B Y Karlan; S Orsulic
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

10.  Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer.

Authors:  Andre F Steinert; Benedikt Proffen; Manuela Kunz; Christian Hendrich; Steven C Ghivizzani; Ulrich Nöth; Axel Rethwilm; Jochen Eulert; Christopher H Evans
Journal:  Arthritis Res Ther       Date:  2009-10-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.